Besides the previously published target Eif4g2 [13], we identified Hpgd and Ptprt as novel miR-139-controlled targets of which depletion in MLL-AF9 AML at least in part phenocopied miR-139 expression. The gene discussed is MLLT3; the disease is acute myeloid leukemia.